Please use this identifier to cite or link to this item:
http://hdl.handle.net/1843/84017
Type: | Artigo de Periódico |
Title: | Statin use in Brazil: findings and implications |
Authors: | Renata Cristina Rezende Macedo do Nascimento Augusto Afonso Guerra Júnior Juliana Álvares Teodoro Isabel Cristina Gomes Brian Godman Marion Bennie Amanj Baker Kurdi Francisco de Assis Acúrcio |
Abstract: | Introduction and objectives: Statins have become an integral part of treatment to reduce cardiac events in patients with cardiovascular disease. However, their use within the public healthcare system in Brazil is unknown. Consequently, we sought to determine and characterize statin use in primary healthcare delivered by the public health system (SUS) in Brazil and evaluate associated patient factors to improve future use. Methods: Cross-sectional study with a national representative sample from five Brazilian regions, derived from the National Survey on Access, Use and Promotion of Rational Use of Medicines using a multi-stage complex sampling plan. Patients over 18 years old were interviewed from July 2014 to May 2015. The prevalences of statin use and self-reported statin adherence were determined amongst medicine users. The associations between statin use and sociodemographic/health condition variables were assessed using logistic regression. Results: A total of 8803 patients were interviewed, of whom 6511 were medicine users. The prevalence of statin use was 9.4% with simvastatin (90.3%), atorvastatin (4.7%) and rosuvastatin (1.9%) being the most used statins. Poor adherence was described by 6.5% of patients. Statin use was significantly associated with age ≥65 years old, higher educational level, residence in the South, metabolic and heart diseases, alcohol consumption and polypharmacy. Conclusions: This is the first population based study in Brazil to assess statin use in SUS primary healthcare patients. Addressing inequalities in access and use of medicines including statins is an important step in achieving the full benefit of statins in Brazil, with the findings guiding future research and policies. |
Subject: | Medicamentos Doenças cardiovasculares |
language: | eng |
metadata.dc.publisher.country: | Brasil |
Publisher: | Universidade Federal de Minas Gerais |
Publisher Initials: | UFMG |
metadata.dc.publisher.department: | FAR - DEPARTAMENTO DE FARMÁCIA SOCIAL |
Rights: | Acesso Aberto |
metadata.dc.identifier.doi: | 10.1080/03007995.2018.1451312 |
URI: | http://hdl.handle.net/1843/84017 |
Issue Date: | 12-Apr-2018 |
metadata.dc.url.externa: | https://strathprints.strath.ac.uk/63471/ |
Appears in Collections: | Artigo de Periódico |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
Statin use in Brazil findings and implications.pdf | 1.49 MB | Adobe PDF | View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.